Vidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral Vidarabine

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
OEM Services
The supplier provides OEM services for popular brands
R&D Capabilities
The supplier has 1 R&D engineers, you can check the Audit Report for more information
to see all verified strength labels (13)
  • Vidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral Vidarabine
  • Vidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral Vidarabine
  • Vidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral Vidarabine
  • Vidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral Vidarabine
  • Vidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral Vidarabine
  • Vidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral Vidarabine
Find Similar Products

Basic Info.

Certification
GMP, ISO 9001, USP, BP
Suitable for
Adult
State
Powder
Purity
>98%
Sample
Available
OEM
Available
MOQ
1kg
Keyword 1
Vidarabine
Keyword 2
Vidarabine Powder
Storage
Dry and Cool Place
Transport Package
Foil Bag/25kg Drum
Specification
98%
Trademark
/
Origin
China
Production Capacity
10000

Product Description

Vidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral Vidarabine

Description 
Adenosine is an endogenous nucleoside that is distributed throughout human cells. It can directly enter the myocardium to generate adenylate through phosphorylation, which participates in myocardial energy metabolism, and also participates in dilating coronary blood vessels and increasing blood flow. It can be used to treat supraventricular tachycardia. Adenosine has physiological effects on the cardiovascular system and many other systems and tissues of the body. Adenosine is an important intermediate used to synthesize adenosine triphosphate (ATP), adenine, adenylate, and arabino adenosine.
Adenosine plays a physiological role on the cardiovascular system and the body's many systems and organizations. Adenosine is used in the synthesis adenosine triphosphate, adenosine (ATP), adenine, adenosine, the vidarabine important intermediates.

Name Vidarabine
Grade Pharmaceutical Grade
Appearance white powder
Specification 98%


Function and Application
1. It has the effect of anti herpes simplex virus HSV-1 and HSV-2, and is used to treat herpes simplex virus meningitis, as well as herpes zoster and varicella infection in immunosuppressed patients. But it has no effect on cytomegalovirus. The monophosphate of this product can inhibit the replication of hepatitis B virus. When the dosage is above 10mg/kg per day, anorexia, nausea, vomiting, diarrhea, elevated transaminase, dizziness, fatigue, etc. may occur. A few can also have bone marrow depression, mainly manifested as leukopenia and thrombocytopenia. This drug has teratogenic effect and is forbidden for pregnant women. Lactating mothers, infants and those with liver and kidney dysfunction should be cautious.
2. To treat chronic hepatitis B, herpes simplex encephalitis, herpes zoster, genital herpes, herpes simplex infection in neonates, varicella zoster infection, herpetic myelitis, keratitis, corneal uveitis, and cytomegalovirus pneumonia in immunocompromised patients.
3. Antiarrhythmic drugs can convert paroxysmal supraventricular tachycardia into sinus rhythm. It is used for supraventricular arrhythmia related to atrioventricular.
4. Antiviral drugs.
5. In the pharmaceutical industry, it is mainly used to manufacture arabinoside; Adenosine triphosphate; Coenzyme and its series products are the main raw materials of drugs such as cyclic adenosine phosphate.
6. It is used to manufacture ATP, arabinoside, coenzyme A, etc.
7. Treat angina pectoris, myocardial infarction, coronary insufficiency, arteriosclerosis, primary hypertension, cerebrovascular disorders, sequelae of stroke, progressive muscular atrophy, etc. Patients with atrioventricular block and acute myocardial infarction should not use it.

Vidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral VidarabineVidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral VidarabineVidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral VidarabineVidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral VidarabineVidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral VidarabineVidarabine Powder CAS 5536-17-4 API Vidarabine Antiviral Vidarabine

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier